0.01
|
0.14 Å
|
7CHC.pdb
|
R
|
A
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB AND BD-368-2 FAB |
View
|
0.0
|
0.0 Å
|
7M6H.pdb
|
A
|
G
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-20 |
View
|
0.0
|
0.0 Å
|
7BEP.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS |
View
|
0.0
|
0.0 Å
|
7L2E.pdb
|
C
|
I
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-18 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.05 Å
|
7LXZ.pdb
|
B
|
F
|
SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT |
View
|
0.0
|
0.03 Å
|
7L3N.pdb
|
B
|
E
|
SARS-COV 2 SPIKE PROTEIN BOUND TO LY-COV555 |
View
|
0.0
|
0.09 Å
|
7CZX.pdb
|
C
|
J
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9 |
View
|
0.0
|
0.0 Å
|
7CHF.pdb
|
R
|
L
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-604 FAB AND BD-368-2 FAB |
View
|
0.0
|
0.06 Å
|
7K43.pdb
|
A
|
H
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
7LCN.pdb
|
K
|
M
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1050.1 |
View
|
0.0
|
0.07 Å
|
7L3N.pdb
|
B
|
D
|
SARS-COV 2 SPIKE PROTEIN BOUND TO LY-COV555 |
View
|
0.0
|
0.0 Å
|
7KXJ.pdb
|
C
|
N
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 3-"UP", ASYMMETRIC |
View
|
0.0
|
0.0 Å
|
7A5R.pdb
|
A
|
L
|
COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT) |
View
|
0.0
|
0.0 Å
|
6XC2.pdb
|
A
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.1 |
View
|
0.0
|
0.0 Å
|
7JW0.pdb
|
A
|
L
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S304 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
7CZT.pdb
|
C
|
M
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G9 |
View
|
0.0
|
0.0 Å
|
7K8S.pdb
|
C
|
N
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) |
View
|
0.0
|
0.05 Å
|
7BEH.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-316 FAB |
View
|
0.0
|
0.0 Å
|
7NDB.pdb
|
B
|
L
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 253H165L FAB |
View
|
0.0
|
0.03 Å
|
7K4N.pdb
|
E
|
G
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
7LXZ.pdb
|
K
|
D
|
SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7M6G.pdb
|
B
|
R
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-15 |
View
|
0.0
|
0.0 Å
|
7CHB.pdb
|
R
|
H
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB |
View
|
0.0
|
0.04 Å
|
7KXJ.pdb
|
B
|
I
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 3-"UP", ASYMMETRIC |
View
|
0.0
|
0.0 Å
|
6XCM.pdb
|
C
|
H
|
STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 1) |
View
|
0.0
|
0.0 Å
|
7CHF.pdb
|
R
|
B
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-604 FAB AND BD-368-2 FAB |
View
|
0.0
|
0.01 Å
|
7ND4.pdb
|
C
|
H
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB |
View
|
0.0
|
0.01 Å
|
7KKL.pdb
|
A
|
B
|
SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY MNB6 |
View
|
0.0
|
0.02 Å
|
7KMG.pdb
|
C
|
B
|
LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.0 Å
|
7NXB.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 P.1 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7CZP.pdb
|
A
|
L
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A1 |
View
|
0.0
|
0.0 Å
|
7ND7.pdb
|
C
|
K
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB |
View
|
0.0
|
0.05 Å
|
7B3O.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH STE90-C11 FAB |
View
|
0.0
|
0.0 Å
|
7KFW.pdb
|
E
|
F
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB) |
View
|
0.0
|
0.18 Å
|
7JV6.pdb
|
A
|
L
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (CLOSED CONFORMATION) |
View
|
0.0
|
0.0 Å
|
7CWS.pdb
|
O
|
N
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7BEN.pdb
|
C
|
D
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
7KN7.pdb
|
A
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH W AND ANTIBODY FAB CC12.3 |
View
|
0.0
|
0.0 Å
|
7LXZ.pdb
|
A
|
H
|
SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7LOP.pdb
|
A
|
B
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 |
View
|
0.0
|
0.0 Å
|
7L2F.pdb
|
B
|
I
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 5-24 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.0 Å
|
7LAB.pdb
|
A
|
S
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1052 |
View
|
0.0
|
0.0 Å
|
7KN5.pdb
|
B
|
F
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODIES VHH E AND U |
View
|
0.0
|
0.0 Å
|
7CJF.pdb
|
C
|
B
|
CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB |
View
|
0.0
|
0.0 Å
|
7KN6.pdb
|
A
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH V AND ANTIBODY FAB CC12.3 |
View
|
0.0
|
0.0 Å
|
7LY2.pdb
|
J
|
E
|
SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7MMO.pdb
|
C
|
E
|
LY-COV1404 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.02 Å
|
7DX4.pdb
|
E
|
H
|
THE STRUCTURE OF FC08 FAB-HA.CE2-RBD COMPLEX |
View
|
0.0
|
0.0 Å
|
7CZT.pdb
|
A
|
L
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G9 |
View
|
0.0
|
0.0 Å
|
6XKP.pdb
|
A
|
M
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-270 |
View
|
0.0
|
0.0 Å
|
7D0C.pdb
|
C
|
F
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3A1 |
View
|
0.0
|
0.0 Å
|
6XC7.pdb
|
A
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.3 AND CR3022 |
View
|
0.0
|
0.0 Å
|
7EAM.pdb
|
B
|
C
|
IMMUNE COMPLEX OF SARS-COV-2 RBD AND CROSS-NEUTRALIZING ANTIBODY 7D6 |
View
|
0.0
|
0.0 Å
|
7L2E.pdb
|
A
|
H
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-18 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.0 Å
|
7CWN.pdb
|
B
|
E
|
P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN |
View
|
0.0
|
0.0 Å
|
7A5R.pdb
|
A
|
H
|
COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT) |
View
|
0.0
|
0.01 Å
|
7CWU.pdb
|
C
|
R
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
6ZER.pdb
|
D
|
G
|
CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB |
View
|
0.0
|
0.0 Å
|
7KN5.pdb
|
A
|
D
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODIES VHH E AND U |
View
|
0.0
|
0.02 Å
|
7KMG.pdb
|
F
|
E
|
LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.0 Å
|
7BEH.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-316 FAB |
View
|
0.0
|
0.0 Å
|
7BEN.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
6XKP.pdb
|
B
|
M
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-270 |
View
|
0.0
|
0.02 Å
|
7JWB.pdb
|
C
|
D
|
SARS COV2 SPIKE ECTODOMAIN WITH ENGINEERED TRIMERIZED VH BINDER |
View
|
0.0
|
0.0 Å
|
7M3I.pdb
|
C
|
A
|
STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, CV2-75 FAB |
View
|
0.0
|
0.03 Å
|
7CWN.pdb
|
B
|
I
|
P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN |
View
|
0.0
|
0.0 Å
|
7CZR.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_2B |
View
|
0.0
|
0.0 Å
|
7L2E.pdb
|
A
|
L
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-18 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.0 Å
|
7LXZ.pdb
|
B
|
G
|
SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7LAB.pdb
|
C
|
L
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1052 |
View
|
0.0
|
0.08 Å
|
7KMG.pdb
|
F
|
D
|
LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.0 Å
|
7LXZ.pdb
|
A
|
F
|
SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7LY2.pdb
|
A
|
F
|
SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7M6I.pdb
|
C
|
L
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-24 |
View
|
0.0
|
0.0 Å
|
7K8S.pdb
|
C
|
L
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) |
View
|
0.0
|
0.0 Å
|
7M6F.pdb
|
E
|
C
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-22 |
View
|
0.0
|
0.0 Å
|
7KKL.pdb
|
D
|
E
|
SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY MNB6 |
View
|
0.0
|
0.0 Å
|
6ZDG.pdb
|
D
|
C
|
ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB |
View
|
0.0
|
0.0 Å
|
7CHC.pdb
|
R
|
H
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB AND BD-368-2 FAB |
View
|
0.0
|
0.0 Å
|
7M7W.pdb
|
S
|
D
|
ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE |
View
|
0.0
|
0.03 Å
|
7K43.pdb
|
E
|
F
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
7CWN.pdb
|
B
|
D
|
P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN |
View
|
0.0
|
0.0 Å
|
7BEL.pdb
|
R
|
A
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS |
View
|
0.0
|
0.0 Å
|
7KXK.pdb
|
B
|
I
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION |
View
|
0.0
|
0.0 Å
|
7L09.pdb
|
A
|
M
|
CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND DOMAIN-SWAPPED ANTIBODY 2G12 FROM MASKED 3D REFINEMENT |
View
|
0.0
|
0.0 Å
|
7KMK.pdb
|
B
|
I
|
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, TWO RBDS BOUND |
View
|
0.0
|
0.0 Å
|
6XCM.pdb
|
C
|
L
|
STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 1) |
View
|
0.0
|
0.0 Å
|
7LXY.pdb
|
A
|
F
|
SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7LXX.pdb
|
A
|
H
|
SARS-COV-2 S/S2M11/S2L28 LOCAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7CZS.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_3B |
View
|
0.0
|
0.21 Å
|
7M6H.pdb
|
B
|
D
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-20 |
View
|
0.0
|
0.0 Å
|
7CWU.pdb
|
A
|
F
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
6XC7.pdb
|
A
|
D
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.3 AND CR3022 |
View
|
0.0
|
0.0 Å
|
7M6E.pdb
|
B
|
C
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19 |
View
|
0.0
|
0.0 Å
|
7M3I.pdb
|
R
|
L
|
STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, CV2-75 FAB |
View
|
0.0
|
0.0 Å
|
7LOP.pdb
|
A
|
C
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 |
View
|
0.0
|
0.01 Å
|
7DEO.pdb
|
D
|
C
|
CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY SCFV |
View
|
0.0
|
0.0 Å
|
6W41.pdb
|
C
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH HUMAN ANTIBODY CR3022 |
View
|
0.0
|
0.0 Å
|
7LD1.pdb
|
B
|
N
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047 |
View
|
0.0
|
0.0 Å
|
6XC4.pdb
|
Z
|
Y
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.3 |
View
|
0.0
|
0.24 Å
|
7K8S.pdb
|
C
|
M
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) |
View
|
0.0
|
0.04 Å
|
7K4N.pdb
|
B
|
D
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.01 Å
|
7ND8.pdb
|
B
|
L
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 384 FAB |
View
|
0.0
|
0.0 Å
|
7M6I.pdb
|
B
|
L
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-24 |
View
|
0.0
|
0.0 Å
|
7NDD.pdb
|
A
|
G
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-159 |
View
|
0.0
|
0.0 Å
|
7NEG.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 FAB |
View
|
0.0
|
0.07 Å
|
7LS9.pdb
|
B
|
D
|
CRYO-EM STRUCTURE OF NEUTRALIZING ANTIBODY 1-57 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.0 Å
|
7KFY.pdb
|
A
|
L
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-F10 FAB) |
View
|
0.0
|
0.0 Å
|
7LSS.pdb
|
B
|
L
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 7 |
View
|
0.0
|
0.0 Å
|
7L02.pdb
|
A
|
M
|
CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO ONE COPY OF DOMAIN-SWAPPED ANTIBODY 2G12 |
View
|
0.0
|
0.0 Å
|
7K8M.pdb
|
E
|
A
|
STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C102 |
View
|
0.0
|
0.0 Å
|
7CAK.pdb
|
C
|
I
|
SARS-COV-2 S TRIMER WITH THREE RBD IN THE OPEN STATE AND COMPLEXED WITH THREE H014 FAB |
View
|
0.0
|
0.0 Å
|
7LOP.pdb
|
A
|
W
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 |
View
|
0.0
|
0.0 Å
|
7KFX.pdb
|
A
|
H
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-C2 FAB) |
View
|
0.0
|
0.0 Å
|
7K8U.pdb
|
A
|
H
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C104 |
View
|
0.0
|
0.0 Å
|
7BEI.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-150 FAB |
View
|
0.0
|
0.1 Å
|
7LOP.pdb
|
A
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 |
View
|
0.0
|
0.05 Å
|
7LXY.pdb
|
J
|
M
|
SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7CZP.pdb
|
C
|
N
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A1 |
View
|
0.0
|
0.0 Å
|
7KML.pdb
|
B
|
M
|
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, THREE RBDS BOUND |
View
|
0.0
|
0.0 Å
|
7LXZ.pdb
|
K
|
E
|
SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7ND4.pdb
|
A
|
E
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB |
View
|
0.0
|
0.0 Å
|
7CZU.pdb
|
A
|
K
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_2B |
View
|
0.02
|
0.16 Å
|
7CHE.pdb
|
R
|
A
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB AND BD-368-2 FAB |
View
|
0.0
|
0.01 Å
|
7CWU.pdb
|
A
|
S
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7LM8.pdb
|
A
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH TWO CROSS-NEUTRALIZING ANTIBODIES CV38-142 AND COVA1- 16 FABS ISOLATED FROM COVID-19 PATIENTS |
View
|
0.0
|
0.0 Å
|
7L56.pdb
|
C
|
G
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43 |
View
|
0.0
|
0.0 Å
|
7LQV.pdb
|
B
|
X
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-8 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE |
View
|
0.0
|
0.0 Å
|
7M6E.pdb
|
B
|
F
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19 |
View
|
0.0
|
0.0 Å
|
6ZFO.pdb
|
A
|
B
|
ASSOCIATION OF TWO COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB |
View
|
0.0
|
0.0 Å
|
7NXA.pdb
|
E
|
B
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 B.1.351 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7KFX.pdb
|
A
|
L
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-C2 FAB) |
View
|
0.0
|
0.06 Å
|
7CZX.pdb
|
B
|
I
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9 |
View
|
0.0
|
0.0 Å
|
7JV4.pdb
|
B
|
D
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (ONE RBD OPEN) |
View
|
0.0
|
0.06 Å
|
7C01.pdb
|
B
|
L
|
MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD |
View
|
0.0
|
0.0 Å
|
7NX7.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE K417N MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
6XC7.pdb
|
A
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.3 AND CR3022 |
View
|
0.0
|
0.0 Å
|
7K8X.pdb
|
A
|
G
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 1) |
View
|
0.0
|
0.08 Å
|
7LS9.pdb
|
B
|
F
|
CRYO-EM STRUCTURE OF NEUTRALIZING ANTIBODY 1-57 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.0 Å
|
6XC2.pdb
|
Z
|
Y
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.1 |
View
|
0.0
|
0.0 Å
|
6ZFO.pdb
|
A
|
C
|
ASSOCIATION OF TWO COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB |
View
|
0.0
|
0.0 Å
|
7NDD.pdb
|
C
|
D
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-159 |
View
|
0.0
|
0.0 Å
|
7KMI.pdb
|
C
|
A
|
LY-COV481 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.08 Å
|
7LY2.pdb
|
B
|
F
|
SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT |
View
|
0.0
|
0.05 Å
|
7KFV.pdb
|
B
|
D
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B12 FAB) |
View
|
0.0
|
0.0 Å
|
6XC3.pdb
|
C
|
A
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.1 AND CR3022 |
View
|
0.0
|
0.0 Å
|
7D00.pdb
|
C
|
J
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-1B8 |
View
|
0.0
|
0.01 Å
|
7CWU.pdb
|
B
|
L
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7BEI.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-150 FAB |
View
|
0.0
|
0.02 Å
|
7BEO.pdb
|
R
|
A
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
7CZV.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_3B |
View
|
0.0
|
0.0 Å
|
7L0N.pdb
|
S
|
N
|
CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY |
View
|
0.0
|
0.0 Å
|
7LQV.pdb
|
C
|
Y
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-8 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE |
View
|
0.0
|
0.0 Å
|
7JV6.pdb
|
A
|
H
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (CLOSED CONFORMATION) |
View
|
0.0
|
0.0 Å
|
7M6E.pdb
|
A
|
H
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19 |
View
|
0.0
|
0.0 Å
|
7KFV.pdb
|
E
|
F
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B12 FAB) |
View
|
0.0
|
0.0 Å
|
7CZU.pdb
|
C
|
N
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_2B |
View
|
0.0
|
0.0 Å
|
7MMO.pdb
|
C
|
A
|
LY-COV1404 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.0 Å
|
7L2C.pdb
|
A
|
L
|
CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 2-51 IN COMPLEX WITH SARS-COV-2 SPIKE N-TERMINAL DOMAIN (NTD) |
View
|
0.0
|
0.0 Å
|
7DEO.pdb
|
D
|
A
|
CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY SCFV |
View
|
0.0
|
0.0 Å
|
7LQV.pdb
|
A
|
H
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-8 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE |
View
|
0.0
|
0.0 Å
|
7DPM.pdb
|
I
|
G
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB |
View
|
0.0
|
0.0 Å
|
6ZDG.pdb
|
D
|
F
|
ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB |
View
|
0.0
|
0.0 Å
|
7CZY.pdb
|
C
|
N
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_2B |
View
|
0.0
|
0.0 Å
|
7CAK.pdb
|
C
|
H
|
SARS-COV-2 S TRIMER WITH THREE RBD IN THE OPEN STATE AND COMPLEXED WITH THREE H014 FAB |
View
|
0.0
|
0.0 Å
|
7CZX.pdb
|
B
|
M
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9 |
View
|
0.0
|
0.0 Å
|
7LY2.pdb
|
B
|
I
|
SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7LY2.pdb
|
J
|
O
|
SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7BEM.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 SCFV |
View
|
0.0
|
0.0 Å
|
7L0N.pdb
|
R
|
A
|
CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY |
View
|
0.0
|
0.0 Å
|
7A5S.pdb
|
A
|
I
|
COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT) |
View
|
0.0
|
0.0 Å
|
7K8S.pdb
|
B
|
N
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) |
View
|
0.0
|
0.0 Å
|
7KZB.pdb
|
C
|
L
|
POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES |
View
|
0.0
|
0.0 Å
|
7BEN.pdb
|
E
|
B
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
7BEN.pdb
|
E
|
F
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
6ZDH.pdb
|
B
|
D
|
SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB |
View
|
0.0
|
0.0 Å
|
6ZDG.pdb
|
A
|
C
|
ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB |
View
|
0.0
|
0.0 Å
|
6ZDG.pdb
|
E
|
L
|
ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB |
View
|
0.0
|
0.0 Å
|
7K8M.pdb
|
E
|
B
|
STRUCTURE OF THE SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C102 |
View
|
0.0
|
0.0 Å
|
7BEL.pdb
|
R
|
L
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS |
View
|
0.0
|
0.0 Å
|
7K43.pdb
|
E
|
C
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
7LM8.pdb
|
A
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH TWO CROSS-NEUTRALIZING ANTIBODIES CV38-142 AND COVA1- 16 FABS ISOLATED FROM COVID-19 PATIENTS |
View
|
0.0
|
0.01 Å
|
7CWM.pdb
|
B
|
J
|
COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE |
View
|
0.0
|
0.0 Å
|
7C01.pdb
|
A
|
D
|
MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD |
View
|
0.0
|
0.0 Å
|
7A5R.pdb
|
B
|
I
|
COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT) |
View
|
0.0
|
0.0 Å
|
7A5S.pdb
|
A
|
L
|
COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT) |
View
|
0.0
|
0.0 Å
|
7L2E.pdb
|
B
|
G
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-18 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.0 Å
|
7KLG.pdb
|
A
|
L
|
SARS-COV-2 RBD IN COMPLEX WITH FAB 15033 |
View
|
0.0
|
0.06 Å
|
7LJR.pdb
|
A
|
S
|
SARS-COV-2 SPIKE PROTEIN TRIMER BOUND TO DH1043 FAB |
View
|
0.0
|
0.0 Å
|
7ND4.pdb
|
C
|
L
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB |
View
|
0.0
|
0.0 Å
|
7K9Z.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE FAB FRAGMENTS OF NEUTRALIZING ANTIBODIES 298 AND 52 |
View
|
0.0
|
0.0 Å
|
7NX9.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7LXZ.pdb
|
A
|
C
|
SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT |
View
|
0.0
|
0.19 Å
|
7JV2.pdb
|
A
|
L
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RECEPTOR-BINDING MOTIF AND FAB VARIABLE DOMAINS) |
View
|
0.0
|
0.0 Å
|
6XC2.pdb
|
Z
|
X
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.1 |
View
|
0.0
|
0.0 Å
|
7NX9.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7KMG.pdb
|
C
|
D
|
LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.02 Å
|
7CAI.pdb
|
C
|
G
|
SARS-COV-2 S TRIMER WITH TWO RBDS IN THE OPEN STATE AND COMPLEXED WITH TWO H014 FAB |
View
|
0.0
|
0.0 Å
|
7CWS.pdb
|
R
|
P
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL |
View
|
0.0
|
0.1 Å
|
7D0D.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3C12_2B |
View
|
0.0
|
0.01 Å
|
7L56.pdb
|
B
|
K
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43 |
View
|
0.0
|
0.0 Å
|
7LD1.pdb
|
A
|
P
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047 |
View
|
0.0
|
0.04 Å
|
7M6I.pdb
|
C
|
H
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-24 |
View
|
0.0
|
0.0 Å
|
7L06.pdb
|
B
|
G
|
CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12 |
View
|
0.0
|
0.0 Å
|
6ZDH.pdb
|
B
|
G
|
SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB |
View
|
0.0
|
0.05 Å
|
7CWN.pdb
|
C
|
L
|
P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN |
View
|
0.0
|
0.0 Å
|
7M6G.pdb
|
B
|
S
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-15 |
View
|
0.0
|
0.0 Å
|
6XDG.pdb
|
E
|
C
|
COMPLEX OF SARS-COV-2 RECEPTOR BINDING DOMAIN WITH THE FAB FRAGMENTS OF TWO NEUTRALIZING ANTIBODIES |
View
|
0.0
|
0.01 Å
|
7CWM.pdb
|
C
|
K
|
COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE |
View
|
0.0
|
0.0 Å
|
7CZT.pdb
|
C
|
I
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G9 |
View
|
0.0
|
0.0 Å
|
7D0C.pdb
|
A
|
L
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3A1 |
View
|
0.0
|
0.0 Å
|
7BEO.pdb
|
R
|
B
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
7K8Z.pdb
|
C
|
N
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135 |
View
|
0.0
|
0.0 Å
|
7L2F.pdb
|
C
|
G
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 5-24 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.0 Å
|
7KXK.pdb
|
B
|
N
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION |
View
|
0.0
|
0.23 Å
|
7M6H.pdb
|
A
|
E
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-20 |
View
|
0.0
|
0.0 Å
|
7KMK.pdb
|
B
|
M
|
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, TWO RBDS BOUND |
View
|
0.0
|
0.06 Å
|
7LS9.pdb
|
A
|
L
|
CRYO-EM STRUCTURE OF NEUTRALIZING ANTIBODY 1-57 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.0 Å
|
7LY2.pdb
|
B
|
M
|
SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT |
View
|
0.01
|
0.13 Å
|
7CWN.pdb
|
A
|
G
|
P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN |
View
|
0.0
|
0.0 Å
|
7L0N.pdb
|
S
|
M
|
CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY |
View
|
0.0
|
0.04 Å
|
7CWU.pdb
|
A
|
O
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7LY3.pdb
|
A
|
C
|
CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB |
View
|
0.0
|
0.03 Å
|
7BEO.pdb
|
X
|
E
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
7NX7.pdb
|
E
|
B
|
CRYSTAL STRUCTURE OF THE K417N MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7NTC.pdb
|
C
|
L
|
TRIMERIC SARS-COV-2 SPIKE ECTODOMAIN BOUND TO P008_056 FAB |
View
|
0.0
|
0.0 Å
|
7CZU.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_2B |
View
|
0.0
|
0.0 Å
|
7CAC.pdb
|
A
|
E
|
SARS-COV-2 S TRIMER WITH ONE RBD IN THE OPEN STATE AND COMPLEXED WITH ONE H014 FAB. |
View
|
0.0
|
0.02 Å
|
7BEN.pdb
|
C
|
G
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
7K45.pdb
|
B
|
H
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND FAB VARIABLE DOMAINS) |
View
|
0.01
|
0.19 Å
|
7MF1.pdb
|
A
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY 47D1 |
View
|
0.0
|
0.0 Å
|
7CH5.pdb
|
R
|
L
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB |
View
|
0.0
|
0.0 Å
|
7C01.pdb
|
B
|
D
|
MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD |
View
|
0.0
|
0.0 Å
|
7CZR.pdb
|
C
|
N
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_2B |
View
|
0.0
|
0.0 Å
|
7CWS.pdb
|
O
|
K
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7M7W.pdb
|
R
|
E
|
ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE |
View
|
0.0
|
0.0 Å
|
7K8W.pdb
|
G
|
N
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C119 |
View
|
0.0
|
0.03 Å
|
7KLG.pdb
|
B
|
I
|
SARS-COV-2 RBD IN COMPLEX WITH FAB 15033 |
View
|
0.0
|
0.0 Å
|
7CWU.pdb
|
A
|
J
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7CZW.pdb
|
A
|
L
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G7 |
View
|
0.0
|
0.0 Å
|
7JW0.pdb
|
B
|
C
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S304 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
6ZDH.pdb
|
C
|
I
|
SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB |
View
|
0.0
|
0.0 Å
|
7K43.pdb
|
B
|
H
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
7C01.pdb
|
A
|
H
|
MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD |
View
|
0.0
|
0.0 Å
|
7LXY.pdb
|
J
|
E
|
SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT |
View
|
0.0
|
0.1 Å
|
7JV6.pdb
|
E
|
G
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (CLOSED CONFORMATION) |
View
|
0.0
|
0.0 Å
|
7CZT.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G9 |
View
|
0.0
|
0.0 Å
|
7LY3.pdb
|
B
|
E
|
CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB |
View
|
0.0
|
0.0 Å
|
7KN7.pdb
|
A
|
B
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH W AND ANTIBODY FAB CC12.3 |
View
|
0.0
|
0.0 Å
|
6ZER.pdb
|
D
|
C
|
CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB |
View
|
0.0
|
0.0 Å
|
7LY3.pdb
|
B
|
F
|
CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB |
View
|
0.0
|
0.36 Å
|
7BWJ.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY WITH RBD |
View
|
0.0
|
0.0 Å
|
7CWS.pdb
|
O
|
H
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7LD1.pdb
|
B
|
H
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047 |
View
|
0.0
|
0.0 Å
|
7M3I.pdb
|
C
|
B
|
STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, CV2-75 FAB |
View
|
0.0
|
0.03 Å
|
7C8W.pdb
|
B
|
A
|
STRUCTURE OF SYBODY MR17 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR- BINDING DOMAIN (RBD) |
View
|
0.0
|
0.0 Å
|
7LAB.pdb
|
B
|
X
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1052 |
View
|
0.0
|
0.0 Å
|
7DPM.pdb
|
L
|
J
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB |
View
|
0.0
|
0.0 Å
|
7KKL.pdb
|
C
|
B
|
SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY MNB6 |
View
|
0.0
|
0.0 Å
|
7NX6.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7BEO.pdb
|
X
|
F
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
7M6D.pdb
|
C
|
A
|
STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODIES BG4-25 AND CR3022 |
View
|
0.0
|
0.0 Å
|
7LOP.pdb
|
Z
|
B
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 |
View
|
0.0
|
0.0 Å
|
7NX8.pdb
|
E
|
B
|
CRYSTAL STRUCTURE OF THE K417T MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7L2F.pdb
|
A
|
H
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 5-24 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.09 Å
|
7A29.pdb
|
B
|
E
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING SYBODIES (SB23) 2-UP CONFORMATION |
View
|
0.0
|
0.07 Å
|
7K8W.pdb
|
G
|
S
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C119 |
View
|
0.0
|
0.0 Å
|
7CZP.pdb
|
C
|
J
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A1 |
View
|
0.0
|
0.0 Å
|
7CH4.pdb
|
R
|
H
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-604 FAB |
View
|
0.0
|
0.0 Å
|
7M6E.pdb
|
E
|
L
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19 |
View
|
0.0
|
0.0 Å
|
7CWN.pdb
|
C
|
N
|
P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN |
View
|
0.0
|
0.01 Å
|
7BEL.pdb
|
R
|
H
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS |
View
|
0.0
|
0.0 Å
|
7D00.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-1B8 |
View
|
0.0
|
0.0 Å
|
7LXY.pdb
|
B
|
M
|
SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT |
View
|
0.0
|
0.02 Å
|
7KXJ.pdb
|
C
|
J
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 3-"UP", ASYMMETRIC |
View
|
0.0
|
0.05 Å
|
7LY2.pdb
|
J
|
M
|
SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT |
View
|
0.02
|
0.34 Å
|
7K90.pdb
|
B
|
H
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C144 |
View
|
0.0
|
0.0 Å
|
7NX8.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE K417T MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7BEJ.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-158 FAB (CRYSTAL FORM 1) |
View
|
0.0
|
0.0 Å
|
7CZZ.pdb
|
C
|
J
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_3B |
View
|
0.0
|
0.0 Å
|
7JVC.pdb
|
A
|
L
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.01 Å
|
7CDI.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P2C-1F11 WITH RBD |
View
|
0.0
|
0.0 Å
|
7CWM.pdb
|
B
|
L
|
COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE |
View
|
0.0
|
0.0 Å
|
7KFW.pdb
|
A
|
L
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB) |
View
|
0.0
|
0.0 Å
|
7NDC.pdb
|
A
|
F
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-159 |
View
|
0.0
|
0.0 Å
|
7CZS.pdb
|
A
|
K
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_3B |
View
|
0.0
|
0.01 Å
|
7BEP.pdb
|
E
|
B
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS |
View
|
0.0
|
0.0 Å
|
7KKL.pdb
|
A
|
F
|
SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY MNB6 |
View
|
0.0
|
0.0 Å
|
7MMO.pdb
|
F
|
D
|
LY-COV1404 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.0 Å
|
7M6F.pdb
|
E
|
D
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-22 |
View
|
0.0
|
0.04 Å
|
7KN5.pdb
|
A
|
C
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODIES VHH E AND U |
View
|
0.0
|
0.0 Å
|
7NXA.pdb
|
E
|
A
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 B.1.351 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7LCN.pdb
|
C
|
H
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1050.1 |
View
|
0.0
|
0.0 Å
|
7CAH.pdb
|
A
|
E
|
THE INTERFACE OF H014 FAB BINDS TO SARS-COV-2 S |
View
|
0.0
|
0.0 Å
|
7NX7.pdb
|
E
|
A
|
CRYSTAL STRUCTURE OF THE K417N MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7CWL.pdb
|
B
|
L
|
SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE |
View
|
0.0
|
0.0 Å
|
7BEP.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS |
View
|
0.0
|
0.04 Å
|
7KFV.pdb
|
B
|
C
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B12 FAB) |
View
|
0.0
|
0.0 Å
|
7NEG.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 FAB |
View
|
0.0
|
0.0 Å
|
7K43.pdb
|
B
|
L
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
7D03.pdb
|
A
|
L
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-2G7 |
View
|
0.0
|
0.0 Å
|
7A5S.pdb
|
A
|
H
|
COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT) |
View
|
0.0
|
0.0 Å
|
7EAM.pdb
|
A
|
L
|
IMMUNE COMPLEX OF SARS-COV-2 RBD AND CROSS-NEUTRALIZING ANTIBODY 7D6 |
View
|
0.06
|
0.36 Å
|
7LAA.pdb
|
A
|
H
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1041 |
View
|
0.0
|
0.01 Å
|
7ND8.pdb
|
B
|
H
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 384 FAB |
View
|
0.0
|
0.0 Å
|
7KN6.pdb
|
A
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH V AND ANTIBODY FAB CC12.3 |
View
|
0.0
|
0.0 Å
|
7KMH.pdb
|
C
|
A
|
LY-COV488 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.03 Å
|
7K8T.pdb
|
A
|
P
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) |
View
|
0.0
|
0.0 Å
|
7A5S.pdb
|
B
|
I
|
COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT) |
View
|
0.0
|
0.0 Å
|
7KFW.pdb
|
E
|
G
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB) |
View
|
0.0
|
0.0 Å
|
7JMW.pdb
|
A
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING ANTIBODY COVA1-16 FAB |
View
|
0.0
|
0.0 Å
|
7LQV.pdb
|
C
|
Z
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-8 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE |
View
|
0.0
|
0.0 Å
|
6XC3.pdb
|
C
|
B
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.1 AND CR3022 |
View
|
0.0
|
0.0 Å
|
7CZV.pdb
|
C
|
J
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_3B |
View
|
0.0
|
0.0 Å
|
7CHC.pdb
|
R
|
L
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB AND BD-368-2 FAB |
View
|
0.0
|
0.0 Å
|
7BYR.pdb
|
B
|
H
|
BD23-FAB IN COMPLEX WITH THE S ECTODOMAIN TRIMER |
View
|
0.0
|
0.05 Å
|
7KFV.pdb
|
A
|
L
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B12 FAB) |
View
|
0.0
|
0.0 Å
|
7CAI.pdb
|
A
|
D
|
SARS-COV-2 S TRIMER WITH TWO RBDS IN THE OPEN STATE AND COMPLEXED WITH TWO H014 FAB |
View
|
0.01
|
0.13 Å
|
7BEP.pdb
|
C
|
D
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS |
View
|
0.0
|
0.0 Å
|
7NDC.pdb
|
C
|
D
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-159 |
View
|
0.0
|
0.0 Å
|
7BEO.pdb
|
R
|
L
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
7JMW.pdb
|
A
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH CROSS-NEUTRALIZING ANTIBODY COVA1-16 FAB |
View
|
0.0
|
0.0 Å
|
6XCN.pdb
|
E
|
F
|
STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2) |
View
|
0.0
|
0.0 Å
|
7M7W.pdb
|
S
|
A
|
ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE |
View
|
0.0
|
0.0 Å
|
6ZDH.pdb
|
A
|
L
|
SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB |
View
|
0.0
|
0.01 Å
|
7K9Z.pdb
|
E
|
A
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE FAB FRAGMENTS OF NEUTRALIZING ANTIBODIES 298 AND 52 |
View
|
0.0
|
0.0 Å
|
7LS9.pdb
|
C
|
G
|
CRYO-EM STRUCTURE OF NEUTRALIZING ANTIBODY 1-57 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.0 Å
|
7KFV.pdb
|
E
|
G
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B12 FAB) |
View
|
0.0
|
0.0 Å
|
7CWN.pdb
|
A
|
M
|
P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN |
View
|
0.0
|
0.0 Å
|
7NDD.pdb
|
B
|
L
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-159 |
View
|
0.0
|
0.0 Å
|
7KML.pdb
|
B
|
I
|
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, THREE RBDS BOUND |
View
|
0.0
|
0.0 Å
|
7NXB.pdb
|
E
|
B
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 P.1 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.12 Å
|
7L5B.pdb
|
A
|
H
|
CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 2-15 IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD). |
View
|
0.0
|
0.0 Å
|
7NTC.pdb
|
C
|
H
|
TRIMERIC SARS-COV-2 SPIKE ECTODOMAIN BOUND TO P008_056 FAB |
View
|
0.0
|
0.0 Å
|
7ND5.pdb
|
B
|
L
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 150 FAB |
View
|
0.0
|
0.02 Å
|
7KXK.pdb
|
C
|
J
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION |
View
|
0.0
|
0.0 Å
|
7KMK.pdb
|
A
|
L
|
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, TWO RBDS BOUND |
View
|
0.0
|
0.0 Å
|
7CHE.pdb
|
R
|
B
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB AND BD-368-2 FAB |
View
|
0.0
|
0.0 Å
|
7K43.pdb
|
A
|
F
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
7CWU.pdb
|
B
|
G
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
6ZFO.pdb
|
E
|
L
|
ASSOCIATION OF TWO COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB |
View
|
0.0
|
0.0 Å
|
7C2L.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH 4A8 |
View
|
0.0
|
0.0 Å
|
7M7W.pdb
|
R
|
H
|
ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE |
View
|
0.0
|
0.0 Å
|
7ND9.pdb
|
B
|
L
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-253H55L FAB |
View
|
0.0
|
0.05 Å
|
7ND7.pdb
|
B
|
F
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB |
View
|
0.0
|
0.02 Å
|
7K4N.pdb
|
A
|
L
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
7C01.pdb
|
B
|
C
|
MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD |
View
|
0.0
|
0.0 Å
|
7K8W.pdb
|
A
|
H
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C119 |
View
|
0.0
|
0.0 Å
|
7BEK.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-158 FAB (CRYSTAL FORM 2) |
View
|
0.0
|
0.0 Å
|
7DPM.pdb
|
C
|
B
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB |
View
|
0.0
|
0.16 Å
|
7D0D.pdb
|
B
|
G
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3C12_2B |
View
|
0.0
|
0.01 Å
|
7CWL.pdb
|
A
|
L
|
SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE |
View
|
0.0
|
0.0 Å
|
7CZV.pdb
|
B
|
I
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_3B |
View
|
0.0
|
0.05 Å
|
7LXZ.pdb
|
K
|
M
|
SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7CJF.pdb
|
C
|
A
|
CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB |
View
|
0.0
|
0.01 Å
|
7KFW.pdb
|
B
|
D
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB) |
View
|
0.0
|
0.0 Å
|
7CWN.pdb
|
A
|
O
|
P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN |
View
|
0.0
|
0.0 Å
|
7NDD.pdb
|
C
|
E
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-159 |
View
|
0.0
|
0.06 Å
|
7K43.pdb
|
B
|
C
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
6ZDH.pdb
|
A
|
H
|
SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB |
View
|
0.0
|
0.0 Å
|
7JW0.pdb
|
E
|
F
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S304 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
7CHF.pdb
|
R
|
H
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-604 FAB AND BD-368-2 FAB |
View
|
0.0
|
0.0 Å
|
7BEP.pdb
|
C
|
G
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS |
View
|
0.0
|
0.0 Å
|
7ND3.pdb
|
B
|
L
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-40 FAB |
View
|
0.0
|
0.06 Å
|
7CWL.pdb
|
C
|
I
|
SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE |
View
|
0.0
|
0.0 Å
|
6ZER.pdb
|
D
|
F
|
CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB |
View
|
0.0
|
0.0 Å
|
7CZY.pdb
|
C
|
J
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_2B |
View
|
0.0
|
0.03 Å
|
7K8T.pdb
|
C
|
H
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) |
View
|
0.0
|
0.0 Å
|
7NDA.pdb
|
C
|
L
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-253H55L FAB |
View
|
0.0
|
0.0 Å
|
7CWS.pdb
|
R
|
G
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7KXK.pdb
|
A
|
L
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION |
View
|
0.0
|
0.0 Å
|
7M6G.pdb
|
C
|
H
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-15 |
View
|
0.0
|
0.0 Å
|
7D00.pdb
|
A
|
K
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-1B8 |
View
|
0.0
|
0.01 Å
|
7L56.pdb
|
A
|
L
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43 |
View
|
0.0
|
0.0 Å
|
7DX4.pdb
|
E
|
L
|
THE STRUCTURE OF FC08 FAB-HA.CE2-RBD COMPLEX |
View
|
0.0
|
0.06 Å
|
7M6I.pdb
|
A
|
N
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-24 |
View
|
0.0
|
0.0 Å
|
7CAI.pdb
|
A
|
E
|
SARS-COV-2 S TRIMER WITH TWO RBDS IN THE OPEN STATE AND COMPLEXED WITH TWO H014 FAB |
View
|
0.0
|
0.0 Å
|
6XCN.pdb
|
C
|
L
|
STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2) |
View
|
0.0
|
0.0 Å
|
6XC3.pdb
|
C
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.1 AND CR3022 |
View
|
0.0
|
0.0 Å
|
7CH4.pdb
|
R
|
L
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-604 FAB |
View
|
0.0
|
0.0 Å
|
7CWS.pdb
|
R
|
F
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7LY0.pdb
|
A
|
H
|
SARS-COV-2 S/S2M11/S2M28 LOCAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7DEO.pdb
|
B
|
C
|
CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY SCFV |
View
|
0.0
|
0.0 Å
|
7B3O.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH STE90-C11 FAB |
View
|
0.03
|
0.2 Å
|
7CHH.pdb
|
A
|
D
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH BD-368-2 FABS |
View
|
0.0
|
0.0 Å
|
7LY0.pdb
|
A
|
L
|
SARS-COV-2 S/S2M11/S2M28 LOCAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7K90.pdb
|
C
|
P
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C144 |
View
|
0.0
|
0.0 Å
|
6XKP.pdb
|
A
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-270 |
View
|
0.0
|
0.0 Å
|
7BEL.pdb
|
X
|
D
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS |
View
|
0.0
|
0.0 Å
|
7CWU.pdb
|
C
|
I
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7CAK.pdb
|
B
|
G
|
SARS-COV-2 S TRIMER WITH THREE RBD IN THE OPEN STATE AND COMPLEXED WITH THREE H014 FAB |
View
|
0.0
|
0.0 Å
|
7EAM.pdb
|
B
|
D
|
IMMUNE COMPLEX OF SARS-COV-2 RBD AND CROSS-NEUTRALIZING ANTIBODY 7D6 |
View
|
0.0
|
0.0 Å
|
7K8T.pdb
|
C
|
P
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) |
View
|
0.0
|
0.0 Å
|
7D0C.pdb
|
C
|
G
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3A1 |
View
|
0.0
|
0.0 Å
|
7K8U.pdb
|
B
|
L
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C104 |
View
|
0.0
|
0.0 Å
|
7LXW.pdb
|
A
|
L
|
SARS-COV-2 S/S2M11/S2X333 LOCAL REFINEMENT |
View
|
0.0
|
0.07 Å
|
7K8X.pdb
|
A
|
E
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 1) |
View
|
0.0
|
0.02 Å
|
7K8V.pdb
|
C
|
N
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C110 |
View
|
0.0
|
0.0 Å
|
7KS9.pdb
|
B
|
L
|
CRYO-EM STRUCTURE OF PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH 910-30 FAB |
View
|
0.0
|
0.0 Å
|
7KKL.pdb
|
D
|
F
|
SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY MNB6 |
View
|
0.02
|
0.29 Å
|
7K90.pdb
|
C
|
O
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C144 |
View
|
0.0
|
0.0 Å
|
7BEP.pdb
|
C
|
I
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS |
View
|
0.0
|
0.0 Å
|
7L0N.pdb
|
R
|
E
|
CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY |
View
|
0.0
|
0.08 Å
|
7ND7.pdb
|
A
|
H
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB |
View
|
0.0
|
0.0 Å
|
7NX8.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE K417T MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7JMP.pdb
|
A
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY COVA2-39 |
View
|
0.0
|
0.0 Å
|
7LOP.pdb
|
Z
|
W
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 |
View
|
0.0
|
0.0 Å
|
7NX6.pdb
|
E
|
A
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7NXB.pdb
|
E
|
A
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 P.1 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7LAB.pdb
|
A
|
T
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1052 |
View
|
0.0
|
0.0 Å
|
7DPM.pdb
|
L
|
K
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB |
View
|
0.0
|
0.0 Å
|
7CWS.pdb
|
Q
|
D
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7CWS.pdb
|
Q
|
E
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7A5R.pdb
|
A
|
I
|
COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT) |
View
|
0.0
|
0.0 Å
|
7L0N.pdb
|
S
|
D
|
CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY |
View
|
0.0
|
0.0 Å
|
7NX9.pdb
|
E
|
A
|
CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7KXJ.pdb
|
B
|
M
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 3-"UP", ASYMMETRIC |
View
|
0.0
|
0.0 Å
|
6XC4.pdb
|
Z
|
X
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.3 |
View
|
0.0
|
0.0 Å
|
7CZQ.pdb
|
C
|
N
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A10 |
View
|
0.0
|
0.01 Å
|
7DEO.pdb
|
B
|
A
|
CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING ANTIBODY SCFV |
View
|
0.01
|
0.13 Å
|
7CWM.pdb
|
A
|
H
|
COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE |
View
|
0.0
|
0.0 Å
|
7K43.pdb
|
A
|
G
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.03 Å
|
7CDJ.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P2C-1A3 WITH RBD |
View
|
0.0
|
0.0 Å
|
7BEL.pdb
|
X
|
F
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS |
View
|
0.0
|
0.0 Å
|
7LAB.pdb
|
C
|
H
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1052 |
View
|
0.0
|
0.0 Å
|
7KFV.pdb
|
A
|
H
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B12 FAB) |
View
|
0.0
|
0.0 Å
|
6ZER.pdb
|
A
|
C
|
CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB |
View
|
0.0
|
0.1 Å
|
7BWJ.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY WITH RBD |
View
|
0.0
|
0.0 Å
|
7CWN.pdb
|
C
|
H
|
P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN |
View
|
0.0
|
0.05 Å
|
7LXZ.pdb
|
A
|
E
|
SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7KMG.pdb
|
F
|
A
|
LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.0 Å
|
7NDA.pdb
|
C
|
H
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-253H55L FAB |
View
|
0.0
|
0.0 Å
|
7NXA.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 B.1.351 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.07 Å
|
6XDG.pdb
|
E
|
B
|
COMPLEX OF SARS-COV-2 RECEPTOR BINDING DOMAIN WITH THE FAB FRAGMENTS OF TWO NEUTRALIZING ANTIBODIES |
View
|
0.0
|
0.0 Å
|
7C2L.pdb
|
B
|
I
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH 4A8 |
View
|
0.0
|
0.0 Å
|
7BEO.pdb
|
X
|
C
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
7KLG.pdb
|
B
|
M
|
SARS-COV-2 RBD IN COMPLEX WITH FAB 15033 |
View
|
0.0
|
0.0 Å
|
7LD1.pdb
|
C
|
N
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047 |
View
|
0.0
|
0.0 Å
|
7JVA.pdb
|
A
|
H
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RECEPTOR-BINDING DOMAIN AND FAB VARIABLE DOMAINS) |
View
|
0.0
|
0.0 Å
|
7K90.pdb
|
B
|
L
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C144 |
View
|
0.0
|
0.0 Å
|
7KN6.pdb
|
A
|
C
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH V AND ANTIBODY FAB CC12.3 |
View
|
0.0
|
0.0 Å
|
7JMO.pdb
|
A
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY COVA2-04 |
View
|
0.0
|
0.0 Å
|
7JVA.pdb
|
A
|
L
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RECEPTOR-BINDING DOMAIN AND FAB VARIABLE DOMAINS) |
View
|
0.0
|
0.0 Å
|
7CAK.pdb
|
A
|
D
|
SARS-COV-2 S TRIMER WITH THREE RBD IN THE OPEN STATE AND COMPLEXED WITH THREE H014 FAB |
View
|
0.0
|
0.0 Å
|
7BYR.pdb
|
B
|
L
|
BD23-FAB IN COMPLEX WITH THE S ECTODOMAIN TRIMER |
View
|
0.0
|
0.0 Å
|
7NDB.pdb
|
B
|
H
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 253H165L FAB |
View
|
0.0
|
0.0 Å
|
7JV4.pdb
|
A
|
H
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (ONE RBD OPEN) |
View
|
0.0
|
0.0 Å
|
7K8Y.pdb
|
D
|
I
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 2) |
View
|
0.0
|
0.0 Å
|
7BEK.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-158 FAB (CRYSTAL FORM 2) |
View
|
0.0
|
0.0 Å
|
7K4N.pdb
|
A
|
H
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
7MMO.pdb
|
F
|
E
|
LY-COV1404 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.0 Å
|
7C01.pdb
|
A
|
L
|
MOLECULAR BASIS FOR A POTENT HUMAN NEUTRALIZING ANTIBODY TARGETING SARS-COV-2 RBD |
View
|
0.0
|
0.0 Å
|
7L2C.pdb
|
B
|
C
|
CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 2-51 IN COMPLEX WITH SARS-COV-2 SPIKE N-TERMINAL DOMAIN (NTD) |
View
|
0.0
|
0.07 Å
|
7E23.pdb
|
A
|
B
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE CA521 NEUTRALIZING ANTIBODY FAB (FOCUSED REFINEMENT ON FAB-RBD) |
View
|
0.0
|
0.0 Å
|
7CZQ.pdb
|
A
|
K
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A10 |
View
|
0.0
|
0.0 Å
|
7NX7.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE K417N MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7NDC.pdb
|
B
|
H
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-159 |
View
|
0.0
|
0.0 Å
|
7CZV.pdb
|
B
|
M
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_3B |
View
|
0.0
|
0.0 Å
|
6XC2.pdb
|
A
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.1 |
View
|
0.0
|
0.0 Å
|
7CZS.pdb
|
C
|
N
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_3B |
View
|
0.0
|
0.0 Å
|
7NDC.pdb
|
B
|
L
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-159 |
View
|
0.0
|
0.08 Å
|
7K9Z.pdb
|
E
|
B
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE FAB FRAGMENTS OF NEUTRALIZING ANTIBODIES 298 AND 52 |
View
|
0.0
|
0.16 Å
|
7ND7.pdb
|
C
|
J
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB |
View
|
0.0
|
0.0 Å
|
7KML.pdb
|
C
|
N
|
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, THREE RBDS BOUND |
View
|
0.0
|
0.0 Å
|
7CZR.pdb
|
A
|
K
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_2B |
View
|
0.0
|
0.0 Å
|
7CHE.pdb
|
R
|
L
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB AND BD-368-2 FAB |
View
|
0.0
|
0.0 Å
|
7LXY.pdb
|
J
|
N
|
SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7L2E.pdb
|
B
|
J
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-18 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.0 Å
|
7KZB.pdb
|
C
|
A
|
POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES |
View
|
0.0
|
0.0 Å
|
7CZZ.pdb
|
B
|
M
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_3B |
View
|
0.0
|
0.03 Å
|
7K8V.pdb
|
A
|
L
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C110 |
View
|
0.0
|
0.0 Å
|
7CWS.pdb
|
Q
|
L
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7NDD.pdb
|
B
|
H
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-159 |
View
|
0.0
|
0.0 Å
|
6XC3.pdb
|
C
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.1 AND CR3022 |
View
|
0.0
|
0.25 Å
|
7L56.pdb
|
C
|
F
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43 |
View
|
0.0
|
0.0 Å
|
7CZZ.pdb
|
B
|
I
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_3B |
View
|
0.0
|
0.0 Å
|
7CZV.pdb
|
C
|
N
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_3B |
View
|
0.0
|
0.02 Å
|
7ND4.pdb
|
B
|
F
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB |
View
|
0.0
|
0.01 Å
|
7CWO.pdb
|
A
|
L
|
SARS-COV-2 SPIKE PROTEIN RBD AND P17 FAB COMPLEX |
View
|
0.01
|
0.22 Å
|
7K8S.pdb
|
B
|
O
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) |
View
|
0.0
|
0.09 Å
|
7CZX.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9 |
View
|
0.0
|
0.0 Å
|
7CH5.pdb
|
R
|
H
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB |
View
|
0.0
|
0.0 Å
|
7KLH.pdb
|
A
|
L
|
SARS-COV-2 RBD IN COMPLEX WITH FAB 15033-7 |
View
|
0.0
|
0.0 Å
|
7M6D.pdb
|
C
|
B
|
STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODIES BG4-25 AND CR3022 |
View
|
0.0
|
0.0 Å
|
6W41.pdb
|
C
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH HUMAN ANTIBODY CR3022 |
View
|
0.0
|
0.0 Å
|
6XKP.pdb
|
B
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-270 |
View
|
0.0
|
0.0 Å
|
7M6D.pdb
|
C
|
L
|
STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODIES BG4-25 AND CR3022 |
View
|
0.0
|
0.0 Å
|
7K8W.pdb
|
A
|
L
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C119 |
View
|
0.0
|
0.04 Å
|
7CHH.pdb
|
B
|
G
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH BD-368-2 FABS |
View
|
0.0
|
0.0 Å
|
7C2L.pdb
|
C
|
J
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH 4A8 |
View
|
0.0
|
0.0 Å
|
7LAA.pdb
|
A
|
L
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1041 |
View
|
0.0
|
0.0 Å
|
7KLH.pdb
|
B
|
I
|
SARS-COV-2 RBD IN COMPLEX WITH FAB 15033-7 |
View
|
0.0
|
0.01 Å
|
7CWL.pdb
|
C
|
K
|
SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE |
View
|
0.0
|
0.15 Å
|
7D0B.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3C12_1B |
View
|
0.0
|
0.07 Å
|
7JV6.pdb
|
B
|
D
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (CLOSED CONFORMATION) |
View
|
0.0
|
0.0 Å
|
7K90.pdb
|
A
|
N
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C144 |
View
|
0.0
|
0.02 Å
|
7CZW.pdb
|
C
|
J
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G7 |
View
|
0.0
|
0.0 Å
|
6ZER.pdb
|
A
|
B
|
CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB |
View
|
0.0
|
0.0 Å
|
7LXY.pdb
|
A
|
H
|
SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7LY2.pdb
|
A
|
H
|
SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
6ZDG.pdb
|
A
|
B
|
ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB |
View
|
0.0
|
0.0 Å
|
6XC7.pdb
|
A
|
C
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CC12.3 AND CR3022 |
View
|
0.06
|
0.44 Å
|
7K8T.pdb
|
B
|
N
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) |
View
|
0.0
|
0.0 Å
|
7CDI.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P2C-1F11 WITH RBD |
View
|
0.0
|
0.0 Å
|
7BEJ.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-158 FAB (CRYSTAL FORM 1) |
View
|
0.0
|
0.0 Å
|
7JVC.pdb
|
E
|
G
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
7ND5.pdb
|
B
|
H
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 150 FAB |
View
|
0.0
|
0.05 Å
|
7BEL.pdb
|
X
|
E
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS |
View
|
0.0
|
0.0 Å
|
7K8T.pdb
|
C
|
L
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) |
View
|
0.01
|
0.14 Å
|
7CWM.pdb
|
C
|
I
|
COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE |
View
|
0.0
|
0.03 Å
|
7JV2.pdb
|
A
|
H
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RECEPTOR-BINDING MOTIF AND FAB VARIABLE DOMAINS) |
View
|
0.0
|
0.0 Å
|
7LSS.pdb
|
B
|
H
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 7 |
View
|
0.0
|
0.0 Å
|
7JV4.pdb
|
A
|
L
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (ONE RBD OPEN) |
View
|
0.0
|
0.03 Å
|
7CWM.pdb
|
B
|
G
|
COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE |
View
|
0.0
|
0.0 Å
|
7NX8.pdb
|
E
|
A
|
CRYSTAL STRUCTURE OF THE K417T MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7CWS.pdb
|
R
|
M
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7CZZ.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_3B |
View
|
0.0
|
0.01 Å
|
7CWL.pdb
|
B
|
J
|
SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE |
View
|
0.01
|
0.13 Å
|
7CWU.pdb
|
C
|
M
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7KXK.pdb
|
C
|
N
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION |
View
|
0.0
|
0.0 Å
|
7M7W.pdb
|
S
|
B
|
ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE |
View
|
0.0
|
0.0 Å
|
7NEH.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 FAB |
View
|
0.0
|
0.0 Å
|
7LD1.pdb
|
C
|
M
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047 |
View
|
0.0
|
0.0 Å
|
7L06.pdb
|
A
|
M
|
CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12 |
View
|
0.0
|
0.0 Å
|
7CAI.pdb
|
B
|
G
|
SARS-COV-2 S TRIMER WITH TWO RBDS IN THE OPEN STATE AND COMPLEXED WITH TWO H014 FAB |
View
|
0.0
|
0.04 Å
|
7M6I.pdb
|
A
|
M
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-24 |
View
|
0.0
|
0.01 Å
|
7JWB.pdb
|
B
|
D
|
SARS COV2 SPIKE ECTODOMAIN WITH ENGINEERED TRIMERIZED VH BINDER |
View
|
0.0
|
0.06 Å
|
7L56.pdb
|
B
|
J
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43 |
View
|
0.0
|
0.0 Å
|
7KLH.pdb
|
B
|
M
|
SARS-COV-2 RBD IN COMPLEX WITH FAB 15033-7 |
View
|
0.0
|
0.0 Å
|
7D4G.pdb
|
B
|
G
|
A PROOF OF CONCEPT FOR NEUTRALIZING ANTIBODY-GUIDED VACCINE DESIGN AGAINST SARS-COV-2 |
View
|
0.0
|
0.03 Å
|
7LOP.pdb
|
Z
|
Y
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 |
View
|
0.0
|
0.0 Å
|
6ZDG.pdb
|
E
|
H
|
ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB |
View
|
0.0
|
0.0 Å
|
6ZDG.pdb
|
A
|
L
|
ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB |
View
|
0.0
|
0.0 Å
|
7NDD.pdb
|
A
|
F
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-159 |
View
|
0.0
|
0.0 Å
|
7CZS.pdb
|
B
|
I
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_3B |
View
|
0.0
|
0.0 Å
|
7ND7.pdb
|
B
|
G
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB |
View
|
0.0
|
0.0 Å
|
7EAM.pdb
|
A
|
H
|
IMMUNE COMPLEX OF SARS-COV-2 RBD AND CROSS-NEUTRALIZING ANTIBODY 7D6 |
View
|
0.0
|
0.03 Å
|
7KXK.pdb
|
A
|
H
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION |
View
|
0.0
|
0.0 Å
|
7CZW.pdb
|
C
|
N
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G7 |
View
|
0.0
|
0.0 Å
|
7LQW.pdb
|
C
|
H
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 2-17 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE |
View
|
0.0
|
0.0 Å
|
7CZX.pdb
|
C
|
N
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9 |
View
|
0.0
|
0.0 Å
|
7LXY.pdb
|
B
|
G
|
SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
6XCN.pdb
|
A
|
B
|
STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2) |
View
|
0.0
|
0.0 Å
|
7KMG.pdb
|
C
|
E
|
LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.0 Å
|
7CZU.pdb
|
C
|
J
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_2B |
View
|
0.0
|
0.0 Å
|
7M6H.pdb
|
C
|
F
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-20 |
View
|
0.0
|
0.0 Å
|
6ZDH.pdb
|
A
|
D
|
SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB |
View
|
0.0
|
0.0 Å
|
7CZS.pdb
|
C
|
J
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_3B |
View
|
0.0
|
0.0 Å
|
7BEN.pdb
|
C
|
I
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
7CWS.pdb
|
Q
|
C
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7BEL.pdb
|
R
|
B
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS |
View
|
0.0
|
0.0 Å
|
7MMO.pdb
|
C
|
B
|
LY-COV1404 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.0 Å
|
7LY2.pdb
|
A
|
L
|
SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT |
View
|
0.01
|
0.19 Å
|
7K8S.pdb
|
A
|
H
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) |
View
|
0.0
|
0.0 Å
|
7BEN.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
7BEN.pdb
|
C
|
F
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
7MMO.pdb
|
F
|
B
|
LY-COV1404 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.0 Å
|
6XE1.pdb
|
E
|
H
|
STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A POTENT NEUTRALIZING ANTIBODY, CV30 FAB |
View
|
0.0
|
0.0 Å
|
7K8Z.pdb
|
A
|
H
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135 |
View
|
0.0
|
0.0 Å
|
7K4N.pdb
|
E
|
F
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
7KMI.pdb
|
C
|
B
|
LY-COV481 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.0 Å
|
7KFY.pdb
|
A
|
H
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-F10 FAB) |
View
|
0.0
|
0.0 Å
|
7CWU.pdb
|
B
|
N
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL |
View
|
0.0
|
0.04 Å
|
7KN5.pdb
|
B
|
D
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODIES VHH E AND U |
View
|
0.0
|
0.12 Å
|
7K8T.pdb
|
B
|
M
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) |
View
|
0.0
|
0.06 Å
|
7BEP.pdb
|
E
|
A
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS |
View
|
0.0
|
0.0 Å
|
7DX4.pdb
|
E
|
A
|
THE STRUCTURE OF FC08 FAB-HA.CE2-RBD COMPLEX |
View
|
0.0
|
0.0 Å
|
7A5R.pdb
|
B
|
H
|
COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT) |
View
|
0.0
|
0.01 Å
|
7KKL.pdb
|
C
|
E
|
SARS-COV-2 SPIKE IN COMPLEX WITH NEUTRALIZING NANOBODY MNB6 |
View
|
0.0
|
0.0 Å
|
7CZZ.pdb
|
C
|
N
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_3B |
View
|
0.0
|
0.0 Å
|
7CZZ.pdb
|
A
|
K
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_3B |
View
|
0.0
|
0.08 Å
|
7CWL.pdb
|
B
|
G
|
SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE |
View
|
0.0
|
0.0 Å
|
7KML.pdb
|
A
|
H
|
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, THREE RBDS BOUND |
View
|
0.0
|
0.0 Å
|
7A5R.pdb
|
B
|
M
|
COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (NON-UNIFORM REFINEMENT) |
View
|
0.0
|
0.0 Å
|
7NDC.pdb
|
A
|
G
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-159 |
View
|
0.0
|
0.06 Å
|
7K8Y.pdb
|
B
|
G
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 2) |
View
|
0.0
|
0.01 Å
|
7KFW.pdb
|
B
|
C
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB) |
View
|
0.0
|
0.0 Å
|
6ZDG.pdb
|
E
|
G
|
ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB |
View
|
0.0
|
0.0 Å
|
7CHB.pdb
|
R
|
L
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB |
View
|
0.0
|
0.0 Å
|
7A5S.pdb
|
B
|
H
|
COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT) |
View
|
0.0
|
0.0 Å
|
7KMG.pdb
|
F
|
B
|
LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.12 Å
|
7LS9.pdb
|
C
|
E
|
CRYO-EM STRUCTURE OF NEUTRALIZING ANTIBODY 1-57 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.01 Å
|
7CWN.pdb
|
A
|
F
|
P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN |
View
|
0.0
|
0.0 Å
|
7KS9.pdb
|
B
|
H
|
CRYO-EM STRUCTURE OF PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH 910-30 FAB |
View
|
0.0
|
0.07 Å
|
7CWO.pdb
|
A
|
H
|
SARS-COV-2 SPIKE PROTEIN RBD AND P17 FAB COMPLEX |
View
|
0.0
|
0.0 Å
|
7CAH.pdb
|
A
|
D
|
THE INTERFACE OF H014 FAB BINDS TO SARS-COV-2 S |
View
|
0.0
|
0.01 Å
|
7CDJ.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 ANTIBODY P2C-1A3 WITH RBD |
View
|
0.0
|
0.0 Å
|
7CZV.pdb
|
A
|
K
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B6_3B |
View
|
0.0
|
0.01 Å
|
7CWN.pdb
|
C
|
J
|
P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN |
View
|
0.0
|
0.0 Å
|
7ND3.pdb
|
B
|
H
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-40 FAB |
View
|
0.0
|
0.02 Å
|
7BEN.pdb
|
E
|
A
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253 AND COVOX-75 FABS |
View
|
0.0
|
0.04 Å
|
7KLH.pdb
|
A
|
H
|
SARS-COV-2 RBD IN COMPLEX WITH FAB 15033-7 |
View
|
0.0
|
0.0 Å
|
7LXZ.pdb
|
B
|
L
|
SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7L0N.pdb
|
R
|
L
|
CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY |
View
|
0.0
|
0.0 Å
|
7CWU.pdb
|
C
|
P
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7K8X.pdb
|
C
|
F
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 1) |
View
|
0.0
|
0.0 Å
|
7CAC.pdb
|
B
|
E
|
SARS-COV-2 S TRIMER WITH ONE RBD IN THE OPEN STATE AND COMPLEXED WITH ONE H014 FAB. |
View
|
0.0
|
0.0 Å
|
7CZY.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_2B |
View
|
0.0
|
0.0 Å
|
7JWB.pdb
|
A
|
D
|
SARS COV2 SPIKE ECTODOMAIN WITH ENGINEERED TRIMERIZED VH BINDER |
View
|
0.0
|
0.0 Å
|
7NX9.pdb
|
E
|
B
|
CRYSTAL STRUCTURE OF THE N501Y MUTANT RECEPTOR BINDING DOMAIN OF SARS- COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.08 Å
|
7A29.pdb
|
A
|
D
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING SYBODIES (SB23) 2-UP CONFORMATION |
View
|
0.01
|
0.2 Å
|
7LOP.pdb
|
A
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 |
View
|
0.0
|
0.0 Å
|
7M7W.pdb
|
R
|
L
|
ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE |
View
|
0.0
|
0.0 Å
|
7D00.pdb
|
C
|
N
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-1B8 |
View
|
0.0
|
0.0 Å
|
7L2E.pdb
|
C
|
K
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-18 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.0 Å
|
7DPM.pdb
|
F
|
D
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB |
View
|
0.0
|
0.0 Å
|
7JMO.pdb
|
A
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY COVA2-04 |
View
|
0.0
|
0.01 Å
|
7KXJ.pdb
|
A
|
H
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 3-"UP", ASYMMETRIC |
View
|
0.0
|
0.0 Å
|
7JV6.pdb
|
E
|
F
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (CLOSED CONFORMATION) |
View
|
0.0
|
0.0 Å
|
7BEP.pdb
|
C
|
F
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-384 AND S309 FABS |
View
|
0.02
|
0.18 Å
|
7CHF.pdb
|
R
|
A
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-604 FAB AND BD-368-2 FAB |
View
|
0.0
|
0.0 Å
|
7M6E.pdb
|
E
|
D
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19 |
View
|
0.0
|
0.0 Å
|
6ZER.pdb
|
A
|
H
|
CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB |
View
|
0.0
|
0.0 Å
|
7CHH.pdb
|
C
|
K
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH BD-368-2 FABS |
View
|
0.0
|
0.0 Å
|
7ND7.pdb
|
A
|
L
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX- 316 FAB |
View
|
0.0
|
0.0 Å
|
7M6D.pdb
|
C
|
H
|
STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH NEUTRALIZING ANTIBODIES BG4-25 AND CR3022 |
View
|
0.0
|
0.09 Å
|
7LXY.pdb
|
B
|
F
|
SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7CWS.pdb
|
O
|
I
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH FC05 AND H014 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7KMH.pdb
|
C
|
B
|
LY-COV488 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.0 Å
|
7KXK.pdb
|
B
|
J
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION |
View
|
0.0
|
0.0 Å
|
7A29.pdb
|
A
|
F
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING SYBODIES (SB23) 2-UP CONFORMATION |
View
|
0.0
|
0.06 Å
|
7CZW.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2G7 |
View
|
0.0
|
0.0 Å
|
6ZER.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB |
View
|
0.0
|
0.0 Å
|
7NXB.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 P.1 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7ND4.pdb
|
B
|
G
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB |
View
|
0.0
|
0.0 Å
|
7KFW.pdb
|
A
|
D
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB) |
View
|
0.0
|
0.0 Å
|
7JVC.pdb
|
B
|
D
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2A4 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
6XCN.pdb
|
A
|
D
|
STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2) |
View
|
0.0
|
0.0 Å
|
7ND6.pdb
|
B
|
L
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-40 FAB |
View
|
0.02
|
0.24 Å
|
7K90.pdb
|
A
|
M
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C144 |
View
|
0.0
|
0.0 Å
|
7CZX.pdb
|
A
|
N
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9 |
View
|
0.0
|
0.0 Å
|
7LXZ.pdb
|
B
|
M
|
SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7L2C.pdb
|
A
|
H
|
CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 2-51 IN COMPLEX WITH SARS-COV-2 SPIKE N-TERMINAL DOMAIN (NTD) |
View
|
0.0
|
0.0 Å
|
6XC4.pdb
|
A
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.3 |
View
|
0.0
|
0.0 Å
|
7L0N.pdb
|
R
|
B
|
CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY |
View
|
0.0
|
0.01 Å
|
7L5B.pdb
|
A
|
L
|
CRYSTALLOGRAPHIC STRUCTURE OF NEUTRALIZING ANTIBODY 2-15 IN COMPLEX WITH SARS-COV-2 SPIKE RECEPTOR-BINDING DOMAIN (RBD). |
View
|
0.0
|
0.0 Å
|
7KLG.pdb
|
A
|
H
|
SARS-COV-2 RBD IN COMPLEX WITH FAB 15033 |
View
|
0.0
|
0.0 Å
|
7ND4.pdb
|
A
|
D
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-88 FAB |
View
|
0.0
|
0.22 Å
|
7JMP.pdb
|
A
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY COVA2-39 |
View
|
0.0
|
0.0 Å
|
7LY2.pdb
|
J
|
N
|
SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT |
View
|
0.0
|
0.08 Å
|
7LXY.pdb
|
A
|
E
|
SARS-COV-2 S/S2M11/S2X333 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7BEL.pdb
|
X
|
C
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-88 AND COVOX-45 FABS |
View
|
0.0
|
0.01 Å
|
7KMK.pdb
|
A
|
H
|
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, TWO RBDS BOUND |
View
|
0.0
|
0.0 Å
|
7L0N.pdb
|
S
|
C
|
CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY |
View
|
0.0
|
0.0 Å
|
7LY2.pdb
|
B
|
G
|
SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7L3N.pdb
|
C
|
D
|
SARS-COV 2 SPIKE PROTEIN BOUND TO LY-COV555 |
View
|
0.0
|
0.0 Å
|
7KZB.pdb
|
C
|
H
|
POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES |
View
|
0.0
|
0.0 Å
|
7CZY.pdb
|
A
|
K
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-2F11_2B |
View
|
0.0
|
0.0 Å
|
7NX6.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.07 Å
|
7KFW.pdb
|
A
|
H
|
STRUCTURAL BASIS FOR A GERMLINE-BIASED ANTIBODY RESPONSE TO SARS-COV-2 (RBD:C1A-B3 FAB) |
View
|
0.0
|
0.0 Å
|
7CAN.pdb
|
B
|
A
|
STRUCTURE OF SYBODY MR17-K99Y IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR-BINDING DOMAIN (RBD) |
View
|
0.0
|
0.08 Å
|
7CWN.pdb
|
B
|
K
|
P17-H014 FAB COCKTAIL IN COMPLEX WITH SARS-COV-2 SPIKE PROTEIN |
View
|
0.0
|
0.0 Å
|
6XKQ.pdb
|
A
|
L
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-250 |
View
|
0.02
|
0.2 Å
|
7CHH.pdb
|
C
|
J
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 S-6P IN COMPLEX WITH BD-368-2 FABS |
View
|
0.0
|
0.07 Å
|
7C8V.pdb
|
B
|
A
|
STRUCTURE OF SYBODY SR4 IN COMPLEX WITH THE SARS-COV-2 S RECEPTOR BINDING DOMAIN (RBD) |
View
|
0.01
|
0.26 Å
|
7K9Z.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH THE FAB FRAGMENTS OF NEUTRALIZING ANTIBODIES 298 AND 52 |
View
|
0.0
|
0.2 Å
|
7LS9.pdb
|
A
|
H
|
CRYO-EM STRUCTURE OF NEUTRALIZING ANTIBODY 1-57 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.01
|
0.19 Å
|
7K8X.pdb
|
B
|
D
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 1) |
View
|
0.0
|
0.0 Å
|
7K8S.pdb
|
A
|
L
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) |
View
|
0.0
|
0.0 Å
|
7BEO.pdb
|
X
|
D
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
7D0C.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-3A1 |
View
|
0.0
|
0.0 Å
|
6ZDH.pdb
|
B
|
F
|
SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB |
View
|
0.0
|
0.0 Å
|
7K4N.pdb
|
B
|
C
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.12 Å
|
7K8T.pdb
|
A
|
O
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) |
View
|
0.0
|
0.0 Å
|
7LD1.pdb
|
A
|
O
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH RECEPTOR BINDING DOMAIN ANTIBODY DH1047 |
View
|
0.0
|
0.0 Å
|
6XE1.pdb
|
E
|
L
|
STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A POTENT NEUTRALIZING ANTIBODY, CV30 FAB |
View
|
0.0
|
0.0 Å
|
7A5S.pdb
|
B
|
M
|
COMPLEX OF SARS-COV-2 SPIKE AND CR3022 FAB (HOMOGENEOUS REFINEMENT) |
View
|
0.0
|
0.21 Å
|
7L56.pdb
|
A
|
H
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN BOUND TO FAB 2- 43 |
View
|
0.0
|
0.0 Å
|
7K43.pdb
|
E
|
D
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2M11 NEUTRALIZING ANTIBODY FAB FRAGMENT |
View
|
0.0
|
0.0 Å
|
7KML.pdb
|
C
|
J
|
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, THREE RBDS BOUND |
View
|
0.0
|
0.0 Å
|
7M7W.pdb
|
R
|
F
|
ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE |
View
|
0.0
|
0.0 Å
|
7CZQ.pdb
|
C
|
J
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A10 |
View
|
0.0
|
0.0 Å
|
7DPM.pdb
|
F
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB |
View
|
0.0
|
0.0 Å
|
7M6E.pdb
|
A
|
G
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG10-19 |
View
|
0.0
|
0.0 Å
|
7CZS.pdb
|
B
|
M
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_3B |
View
|
0.0
|
0.0 Å
|
7DPM.pdb
|
F
|
E
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB |
View
|
0.0
|
0.0 Å
|
7L2D.pdb
|
A
|
H
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 1-87 IN COMPLEX WITH PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN |
View
|
0.0
|
0.0 Å
|
7L0N.pdb
|
R
|
H
|
CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY |
View
|
0.0
|
0.0 Å
|
7LOP.pdb
|
Z
|
V
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 |
View
|
0.0
|
0.0 Å
|
7LXW.pdb
|
A
|
H
|
SARS-COV-2 S/S2M11/S2X333 LOCAL REFINEMENT |
View
|
0.01
|
0.12 Å
|
7K8S.pdb
|
B
|
P
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 1) |
View
|
0.0
|
0.0 Å
|
6ZFO.pdb
|
E
|
H
|
ASSOCIATION OF TWO COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB |
View
|
0.0
|
0.0 Å
|
7KN7.pdb
|
A
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODY VHH W AND ANTIBODY FAB CC12.3 |
View
|
0.0
|
0.0 Å
|
7L0N.pdb
|
S
|
F
|
CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY |
View
|
0.0
|
0.0 Å
|
7CHE.pdb
|
R
|
H
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 RBD IN COMPLEX WITH BD-236 FAB AND BD-368-2 FAB |
View
|
0.0
|
0.0 Å
|
7LY3.pdb
|
A
|
D
|
CRYSTAL STRUCTURE OF SARS-COV-2 S NTD BOUND TO S2M28 FAB |
View
|
0.0
|
0.0 Å
|
7M6F.pdb
|
A
|
H
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG1-22 |
View
|
0.0
|
0.0 Å
|
6XCM.pdb
|
B
|
N
|
STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 1) |
View
|
0.0
|
0.0 Å
|
7BEO.pdb
|
R
|
H
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN A TERNARY COMPLEX WITH COVOX-253H55L AND COVOX-75 FABS |
View
|
0.0
|
0.0 Å
|
7CZX.pdb
|
A
|
K
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B9 |
View
|
0.0
|
0.0 Å
|
7ND6.pdb
|
B
|
H
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-40 FAB |
View
|
0.0
|
0.0 Å
|
7CAK.pdb
|
A
|
E
|
SARS-COV-2 S TRIMER WITH THREE RBD IN THE OPEN STATE AND COMPLEXED WITH THREE H014 FAB |
View
|
0.0
|
0.0 Å
|
7NXA.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 B.1.351 VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7LM8.pdb
|
A
|
M
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH TWO CROSS-NEUTRALIZING ANTIBODIES CV38-142 AND COVA1- 16 FABS ISOLATED FROM COVID-19 PATIENTS |
View
|
0.0
|
0.1 Å
|
7LJR.pdb
|
A
|
T
|
SARS-COV-2 SPIKE PROTEIN TRIMER BOUND TO DH1043 FAB |
View
|
0.0
|
0.0 Å
|
7KLH.pdb
|
A
|
M
|
SARS-COV-2 RBD IN COMPLEX WITH FAB 15033-7 |
View
|
0.0
|
0.0 Å
|
7ND9.pdb
|
B
|
H
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ONE RBD UP) IN COMPLEX WITH COVOX-253H55L FAB |
View
|
0.0
|
0.0 Å
|
6ZDH.pdb
|
C
|
G
|
SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY EY6A FAB |
View
|
0.0
|
0.11 Å
|
7KMG.pdb
|
C
|
A
|
LY-COV555 NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 |
View
|
0.0
|
0.0 Å
|
7KN5.pdb
|
A
|
E
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN COMPLEXED WITH NANOBODIES VHH E AND U |
View
|
0.0
|
0.0 Å
|
7CHC.pdb
|
R
|
B
|
CRYSTAL STRUCTURE OF THE SARS-COV-2 S RBD IN COMPLEX WITH BD-629 FAB AND BD-368-2 FAB |
View
|
0.0
|
0.0 Å
|
7CZQ.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A10 |
View
|
0.0
|
0.0 Å
|
7K8X.pdb
|
B
|
F
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 1) |
View
|
0.0
|
0.0 Å
|
7K8Z.pdb
|
A
|
L
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135 |
View
|
0.0
|
0.0 Å
|
7JV4.pdb
|
C
|
F
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (ONE RBD OPEN) |
View
|
0.0
|
0.0 Å
|
7M3I.pdb
|
R
|
H
|
STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, CV2-75 FAB |
View
|
0.0
|
0.0 Å
|
7LCN.pdb
|
A
|
B
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1050.1 |
View
|
0.0
|
0.0 Å
|
7NDC.pdb
|
C
|
E
|
EM STRUCTURE OF SARS-COV-2 SPIKE GLYCOPROTEIN (ALL RBD DOWN) IN COMPLEX WITH COVOX-159 |
View
|
0.0
|
0.0 Å
|
7KXK.pdb
|
B
|
M
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION |
View
|
0.0
|
0.0 Å
|
6ZDG.pdb
|
D
|
G
|
ASSOCIATION OF THREE COMPLEXES OF LARGELY STRUCTURALLY DISORDERED SPIKE ECTODOMAIN WITH BOUND EY6A FAB |
View
|
0.0
|
0.0 Å
|
6XCN.pdb
|
E
|
G
|
STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2) |
View
|
0.0
|
0.0 Å
|
7CZR.pdb
|
C
|
J
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P5A-1B8_2B |
View
|
0.0
|
0.0 Å
|
6ZER.pdb
|
E
|
H
|
CRYSTAL STRUCTURE OF RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH EY6A FAB |
View
|
0.0
|
0.0 Å
|
7K8Y.pdb
|
B
|
I
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C121 (STATE 2) |
View
|
0.0
|
0.03 Å
|
7D03.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH FABP5A-2G7 |
View
|
0.0
|
0.0 Å
|
7LM8.pdb
|
A
|
N
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE PROTEIN RECEPTOR-BINDING DOMAIN IN COMPLEX WITH TWO CROSS-NEUTRALIZING ANTIBODIES CV38-142 AND COVA1- 16 FABS ISOLATED FROM COVID-19 PATIENTS |
View
|
0.0
|
0.03 Å
|
7CWU.pdb
|
B
|
H
|
SARS-COV-2 SPIKE PROTEINS TRIMER IN COMPLEX WITH P17 AND FC05 FABS COCKTAIL |
View
|
0.0
|
0.0 Å
|
7K8Z.pdb
|
C
|
M
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C135 |
View
|
0.0
|
0.0 Å
|
7LXZ.pdb
|
K
|
N
|
SARS-COV-2 S/S2M11/S2L28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7KXJ.pdb
|
A
|
L
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 3-"UP", ASYMMETRIC |
View
|
0.0
|
0.0 Å
|
7CAC.pdb
|
B
|
D
|
SARS-COV-2 S TRIMER WITH ONE RBD IN THE OPEN STATE AND COMPLEXED WITH ONE H014 FAB. |
View
|
0.0
|
0.0 Å
|
7M6H.pdb
|
B
|
F
|
STRUCTURE OF THE SARS-COV-2 S 2P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, BG7-20 |
View
|
0.0
|
0.0 Å
|
6XCM.pdb
|
B
|
S
|
STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 1) |
View
|
0.0
|
0.0 Å
|
7KXK.pdb
|
A
|
N
|
SARS-COV-2 SPIKE PROTEIN IN COMPLEX WITH FAB 15033-7, 2-"UP"-1-"DOWN" CONFORMATION |
View
|
0.0
|
0.04 Å
|
7K45.pdb
|
B
|
L
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2E12 NEUTRALIZING ANTIBODY FAB FRAGMENT (LOCAL REFINEMENT OF THE RBD AND FAB VARIABLE DOMAINS) |
View
|
0.0
|
0.0 Å
|
6XCN.pdb
|
C
|
H
|
STRUCTURE OF THE SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH THE C105 NEUTRALIZING ANTIBODY FAB FRAGMENT (STATE 2) |
View
|
0.0
|
0.08 Å
|
7LOP.pdb
|
Z
|
X
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH ANTIBODIES CV05-163 AND CR3022 |
View
|
0.0
|
0.0 Å
|
6XC4.pdb
|
A
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CC12.3 |
View
|
0.0
|
0.0 Å
|
6XKQ.pdb
|
A
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH NEUTRALIZING ANTIBODY CV07-250 |
View
|
0.0
|
0.0 Å
|
7KML.pdb
|
A
|
L
|
CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE IN COMPLEX WITH FAB 15033-7, THREE RBDS BOUND |
View
|
0.0
|
0.01 Å
|
7CWM.pdb
|
A
|
L
|
COMPLEX OF SARS-COV-2 SPIKE PROTEIN AND FAB P17 WITH ONE RBD IN OPEN STATE AND TWO RBD IN CLOSED STATE |
View
|
0.0
|
0.0 Å
|
7LQV.pdb
|
B
|
W
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-8 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE |
View
|
0.0
|
0.0 Å
|
7LQV.pdb
|
A
|
L
|
CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY 4-8 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE |
View
|
0.0
|
0.1 Å
|
7A29.pdb
|
C
|
F
|
CRYO-EM STRUCTURE OF THE SARS-COV-2 SPIKE PROTEIN BOUND TO NEUTRALIZING SYBODIES (SB23) 2-UP CONFORMATION |
View
|
0.0
|
0.0 Å
|
7KLG.pdb
|
A
|
M
|
SARS-COV-2 RBD IN COMPLEX WITH FAB 15033 |
View
|
0.0
|
0.0 Å
|
7NX6.pdb
|
E
|
B
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-222 AND EY6A FABS |
View
|
0.0
|
0.0 Å
|
7LAB.pdb
|
B
|
Y
|
STRUCTURE OF SARS-COV-2 S PROTEIN IN COMPLEX WITH N-TERMINAL DOMAIN ANTIBODY DH1052 |
View
|
0.0
|
0.0 Å
|
7D4G.pdb
|
B
|
N
|
A PROOF OF CONCEPT FOR NEUTRALIZING ANTIBODY-GUIDED VACCINE DESIGN AGAINST SARS-COV-2 |
View
|
0.0
|
0.0 Å
|
7CZP.pdb
|
A
|
H
|
S PROTEIN OF SARS-COV-2 IN COMPLEX BOUND WITH P2B-1A1 |
View
|
0.0
|
0.09 Å
|
7CWL.pdb
|
A
|
H
|
SARS-COV-2 SPIKE PROTEIN AND P17 FAB COMPLEX WITH ONE RBD IN CLOSE STATE |
View
|
0.0
|
0.0 Å
|
7BEM.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 SCFV |
View
|
0.0
|
0.0 Å
|
7DPM.pdb
|
C
|
A
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB |
View
|
0.0
|
0.0 Å
|
7KZB.pdb
|
C
|
B
|
POTENT SARS-COV-2 BINDING AND NEUTRALIZATION THROUGH MATURATION OF ICONIC SARS-COV-1ANTIBODIES |
View
|
0.0
|
0.0 Å
|
7DPM.pdb
|
I
|
H
|
CRYSTAL STRUCTURE OF SARS-COV-2 SPIKE RBD IN COMPLEX WITH MW06 FAB |
View
|
0.0
|
0.0 Å
|
7JV6.pdb
|
B
|
C
|
SARS-COV-2 SPIKE IN COMPLEX WITH THE S2H13 NEUTRALIZING ANTIBODY (CLOSED CONFORMATION) |
View
|
0.0
|
0.0 Å
|
7NEH.pdb
|
E
|
L
|
CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 SPIKE GLYCOPROTEIN IN COMPLEX WITH COVOX-269 FAB |
View
|
0.0
|
0.0 Å
|
7K8T.pdb
|
B
|
L
|
STRUCTURE OF THE SARS-COV-2 S 6P TRIMER IN COMPLEX WITH THE HUMAN NEUTRALIZING ANTIBODY FAB FRAGMENT, C002 (STATE 2) |
View
|
0.0
|
0.0 Å
|
7M7W.pdb
|
S
|
C
|
ANTIBODIES TO THE SARS-COV-2 RECEPTOR-BINDING DOMAIN THAT MAXIMIZE BREADTH AND RESISTANCE TO VIRAL ESCAPE |
View
|
0.0
|
0.05 Å
|
7LY2.pdb
|
A
|
E
|
SARS-COV-2 S/S2M11/S2M28 GLOBAL REFINEMENT |
View
|
0.0
|
0.0 Å
|
7CAI.pdb
|
B
|
F
|
SARS-COV-2 S TRIMER WITH TWO RBDS IN THE OPEN STATE AND COMPLEXED WITH TWO H014 FAB |
View
|